Skip to content

Lybocent

Active Private limited companyfounded 2023active for 3 yearsHundelgemsesteenweg 27, 9050 GhentKBO/BCE: BE 0802.581.859

Lifetime

2 annual accounts with figures on one time axis
peak €12,557 (2025)
€12,557▲ 62.8%
peak €8,259 (2025)
€8,259▲ 49.0%
peak €18,802 (2025)
€18,802▲ 78.3%
€64,472▲ 13×
Board2 names since 2023
2 directors and 1 other
Documentsfilings and deeds
30-01-20261 day before the deadline
2025micro format
Gross margin from €7,714 to €12,557Result from €5,543 to €8,259Equity from €10,543 to €18,802Debts from €5,008 to €64,472Cash from €130 to €3,010

Key points

from the 2025 annual accounts

Debts

€64,472 ▲ 13×
Other debts
+39,683
Suppliers
+14,177
Taxes and wages
+5,604

Debts rose by €59,464 in 2025.

Investments

€2,316 22.1 × depreciation

Green is investment, beige is depreciation.

Liquidity

1.26 was 3.11 in 2024

Short-term debts rose from €5,008 to €64,472.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 7,983 companies had the same profile as Lybocent has now. Each dot stands for 20 companies, two years later.

94.2%
were still trading
1.9%
stopped another way
3.6%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more

Another 0.3% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 7,983 companies, not a prediction for Lybocent. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Director
  • founderdeed of 13-06-2023
  • founderdeed of 13-06-2023
Board & ownership

Recent changes

Registered office moved from Evergem to Ghent New registered office: Hundelgemsesteenweg 27, 9050 Gent (Ledeberg) · Previous registered office: Walgracht 1, 9940 Evergem · “Algemene voedingswaren en verbruiksartikelen, specerijen, biscuiterie, patisserie en confiserie, brood, gebak…” (deed in Dutch) · General meeting of 25-08-2026 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0802581859
Incorporation Founding capital of €5,000, 100 shares · Founders: and · Appointments: (director) and (director) · published on 13-06-2023 · Gazette deed
First establishment Alvo Verso, Hundelgemsesteenweg 27, Ghent
All 6 events

Comparable companies

same main activity, similar in size and age
Company
Lybocent Ghent - - 22.6% -
BOUCHERIE ATLAS Ronse - - 3.4% -
NEW LAHORE Dour €1.0m -1.7% 9.9% -
M.S.G. STORE Charleroi - - 70.3% -
FAMI BUSINESS Anderlecht €0.7m 0.5% 15.0% -
Kabul Oudenaarde €0.8m 1.8% 28.1% -
Watan Market Aalst - - -11.2% -

These companies have the same main activity as Lybocent: non-specialised retail sale with food, beverages or tobacco predominating (NACE 47110). They are comparable in size and age: total assets between €71,900 and €104,000, founded between 2022 and 2024.

Official details

Source: KBO
Status
Active since 09-06-2023Normal situation
Activity
Non-specialised retail sale with food, beverages or tobacco predominatingNACE 47110and 6 others
Establishment unit
2.346.630.1369050 Ghent, since 09-06-2023
Financial year end
30 June
Peppol
Reachable since 17-01-2025
Company details

Annual accounts to 30-06-2025

≈ €370,000estimated
€83,274▲ 436%
Filing
Filed on 30-01-2026, 1 day before the end of the filing period
Financials

Insights on Lybocent

The 2025 annual accounts show equity of €18,802 and a net result of €8,259. Its solvency ranks better than 41% of 25,237 sector peers (NACE 47, financial year 2025).

The company has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Lybocent

What is the company number of Lybocent?
The company number of Lybocent is 0802.581.859. The VAT number is the same number with BE in front: BE 0802.581.859.
Where is Lybocent based?
The registered office is at Hundelgemsesteenweg 27, 9050 Ghent.Company details
What does Lybocent do?
According to the KBO register, the main activity is non-specialised retail sale with food, beverages or tobacco predominating (NACE 47110).
What is the legal form of Lybocent?
Lybocent is a private limited company (BV).
When was Lybocent founded?
Lybocent was founded on 09-06-2023.
Is Lybocent still active?
Yes, Lybocent is an active enterprise in the KBO register.
What is the turnover of Lybocent?
The turnover in financial year 2025 is ≈ €370,000. This figure is estimated from the gross margin of €12,557 and 301 comparable companies (NACE 47110). It probably lies between €190,000 and €660,000. It is a rough estimate.Financials
Is Lybocent profitable?
In financial year 2025, Lybocent made a profit of €8,259.
Where can I find the annual accounts of Lybocent?
Lybocent filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Lybocent due?
Lybocent must file the annual accounts for financial year 2026 by 31-01-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.